Brentuximab Vedotin for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey
Annals of Hematology - Germany
doi 10.1007/s00277-014-2215-9
Full Text
Open PDFAbstract
Available in full text
Date
September 18, 2014
Authors
Publisher
Springer Science and Business Media LLC